I-Mab Announces Share Purchase Plans by the Company and the Senior Management
- Written by PR Newswire
![]() |
GAITHERSBURG, Md. and SHANGHAI, Aug. 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it plans to implement share repurchases pursuant to the share repurchase program...
Read more: I-Mab Announces Share Purchase Plans by the Company and the Senior Management















